Cellular Procoagulant Activity Dictates Clot Structure and Stability as a Function of Distance From the Cell Surface by Campbell, R. A. et al.
Cellular procoagulant activity dictates clot structure and stability
as a function of distance from the cell surface
Robert A. Campbell1, Katherine A. Overmyer1, C. Robert Bagnell1, and Alisa S. Wolberg1,2
1 Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC
27599-7525
2 Carolina Cardiovascular Biology Center, University of North Carolina, Chapel Hill, NC 27599
Abstract
Background—Thrombin concentration modulates fibrin structure and fibrin structure modulates
clot stability; however, the impact of localized, cell surface-driven in situ thrombin generation on
fibrin structure and stability has not previously been evaluated.
Methods—Human fibroblasts were incubated with factors Xa, Va, prothrombin and fibrinogen, or
plasma. Fibrin formation, structure, and lysis were examined using laser scanning confocal
microscopy and transmission electron microscopy.
Results: in situ thrombin generation on the cell surface produced clots with a significantly denser
fiber network in a 10-μm region proximal versus distal to (40 – 50 μm) the cell surface. This
morphology was not altered by addition of integrin-blocking RGDS peptide and was not apparent in
clots made by exogenous thrombin addition, suggesting that spatial morphology was dictated
predominantly by localized thrombin generation on the fibroblast surface. The fibrin network lysed
more rapidly distal versus proximal to the cell surface, suggesting that the clot’s structural
heterogeneity affected its fibrinolytic stability.
Conclusions: in situ thrombin generation on the cell surface modulates the three-dimensional
structure and stability of the clot. Thrombus formation in vivo may reflect the ability of the local cell
population to support thrombin generation and therefore, the three-dimensional structure and stability
of the fibrin network.
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Following vascular injury, thrombin-catalyzes the enzymatic conversion of soluble fibrinogen
to an insoluble fibrin network. The fibrin network stabilizes the primary platelet plug, enabling
it to withstand the rigors of blood flow during wound healing. A growing number of studies
suggest that abnormal fibrin structure makes clots overly stable or friable during this process,
contributing to an individual’s risk of thrombosis and embolism.1–4
Mechanisms of fibrin production and clot assembly have been elucidated primarily from
studies in which a specific amount of thrombin is added to purified fibrinogen. These studies
have shown that the thrombin concentration present at the time of fibrin gelation influences
fibrin clot structure.5–9 Low thrombin concentrations produce porous clots composed of thick
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fibrin fibers, while high thrombin concentrations produce clots composed of a dense network
of thin fibers. Additional studies have correlated fibrin architecture with a clot’s resistance to
mechanical and fibrinolytic disruption.8–11 Clots composed of a dense network of thin fibrin
fibers are more resistant to fibrinolysis compared to clots composed of a porous network of
thick fibers. In vivo, however, thrombin generation is a dynamic process in which the
concentration of thrombin actively changes during the reaction course in accord with the local
conditions. Importantly, and in contrast to in vitro experiments initiated by the addition of
exogenous thrombin to fibrinogen, thrombin generation in vivo is localized to a cell surface.
A recent study using real-time videomicroscopy demonstrated that the procoagulant activity
of tissue factor-bearing cells regulates the fibrin formation rate up to 200 μm from the cell
surface, but does not modulate clot growth further from the cell.12 These findings suggest that
the majority of thrombin generated on the initiating cell is spatially restricted to the region
surrounding the cell, with limited diffusion to distal regions of the reaction milieu. Thus,
different regions of the growing thrombus are exposed to different concentrations of thrombin,
as a function of time and distance from the source of prothrombinase activity. Together, these
findings suggest that when thrombin generation is localized to a cell surface, the resulting fibrin
structure and stability reflects the specific procoagulant activity of the local cells, as well as
the spatial location of the fibrin with respect to the cell surface.
In the current study, we examined fibrin structure and stability arising as a function of in situ
thrombin generation on a cell surface. To specifically focus on the role of the cell surface in
determining clot structure, reactions were performed using purified proteins or plasma in the
absence of platelets or microparticles. We observed that fibrin architecture reflected the
distance of fibrin from the cell surface, but not RGD-mediated interactions between the cell
surface and the fibrin network. This spatial heterogeneity in clot structure caused differential
rates of clot formation and lysis proximal versus distal to the cell surface. Our results suggest
that in situ thrombin generation on a cell surface modulates clot structure and stability in three
dimensions.
MATERIALS AND METHODS
In situ thrombin generation and fibrin clot formation
The source of proteins and materials used is listed in the Supplemental Data section. Fibroblasts
were washed with PBS and immediately incubated with factors Xa, Va, and CaCl2 (1 nM, 5
nM, 5 mM, final, respectively) and prothrombin (0.014 μM or 1.4 μM, final, as indicated) in
HBS. Thrombin generation was measured by quenching 10 μL aliquots of supernatant with 90
μL of 20 mM N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (pH 7.4), 150 mM NaCl
(HBS) containing 10 mM ethylenediamine tetraacetic acid (EDTA) and 1 mg/mL bovine serum
albumin (BSA). Quenched reactions were diluted 1:10 in HBS containing 1 mM EDTA and
0.5 mM Chromozym Th. The substrate cleavage rate (change in absorbance at 405 nm
versus time) was measured using a SpectraMax 340PC microplate reader (Molecular Devices,
Sunnyvale, CA).15 Clot formation was monitored at 405 nm in parallel experiments that
included 2 mg/mL fibrinogen.8, 13–15 In reactions in which clot formation was initiated by
exogenous thrombin addition, fibrinogen, CaCl2, and 2 nM thrombin (final) were pre-mixed
and immediately added to the cells.
Structural Analysis by Laser Scanning Confocal Microscopy (LSCM)
Cells were grown to confluence on LabTek II Chamber uncoated #1.5 cover-glasses (Nalge
Nunc International, Naperville, IL). Clots were formed as above with the addition of 10 μg
AlexaFluor-488-labeled fibrinogen/150 μL sample. Clot formation was allowed to proceed
until a constant final turbidity was reached in separate, parallel reactions. In experiments
performed in the absence of cells, chambers were pretreated with SigmaCote (Sigma, St. Louis,
Campbell et al. Page 2













MO) to eliminate surface effects of glass on the polymerizing fibrin.16 For lysis studies, cells
were grown to confluence on MatTek uncoated #1.5 glass 35 mm dishes (Ashland, MA). Clots
were formed as above in the presence of 0.024 μM plasmin (final). Chambers were immediately
scanned at the cell surface and 50 μm above the cell surface and then every 15 seconds at each
location until complete lysis. Conditions for LSCM and analysis are described in the
Supplemental Data section.
Clot formation in normal pooled plasma
Cells were grown to confluence on sterile glass chamber slides for LSCM and sterile
Thermanox tissue culture cover slips (Miles Laboratories, Naperville, IL) or in eight well
Permanox chamber slides (Nalge Nunc International, Rochester, NY) for transmission electron
microscopy (TEM). Cells were washed with PBS and clots were formed by incubating
fibroblasts with re-calcified (10 mM, final) platelet-free plasma plus 10 μg of AlexaFluor-488-
labeled fibrinogen for two hours. Conditions for TEM are described in the Supplemental Data
section.
Statistical Methods
Pair-wise comparisons were performed using a Student’s t-test; p < 0.05 was considered
significant.
RESULTS
The thrombin generation rate modulates the onset and rate of fibrin clot formation
We incubated human fibroblasts with factors Xa and Va and varied the prothrombin
concentration to modulate the thrombin generation rate. We monitored thrombin activity with
a chromogenic substrate and observed a 41-fold increase in the thrombin generation rate in the
presence of 1.4 vs. 0.014 μM prothrombin (p < 0.007) (Table I, Figure S1A). To determine the
effect of thrombin generation rate on clot formation, plasma fibrinogen (2 mg/mL, final) was
included in reactions and clot formation was monitored by turbidity. Clot formation during
high thrombin generation rates (1.4 μM prothrombin) exhibited a shortened onset and 2.2-fold
increased polymerization rate compared to clot formation during low thrombin generation rates
(Table I, Figure S1B). Interestingly, despite the significant difference in onset and fibrin
polymerization rate, clots formed during high thrombin generation rates had only slightly lower
final turbidities than clots formed during low thrombin generation rates (Table I, Figure S1B).
Such a non-linear relationship between fibrin polymerization rate and final turbidity has been
observed in previous studies performed in the presence and absence of cells.5–9, 14, 15, 17
Nonetheless, because the onset and polymerization rate are indicative of fibrin structure, these
measurements suggested that clots formed during high thrombin generation rates had a
different structure than clots formed during low thrombin generation rates.
Cells modulate fibrin structural characteristics in three dimensions
We next examined the fibrin structure of clots formed during in situ thrombin generation on
the cell surface using LSCM. LSCM permits the investigation of unfixed, fully hydrated
samples; data from this technique can be used to recreate three-dimensional images permitting
structural analysis as a function of focal depth within the sample. LSCM enabled us to examine
inter-clot differences in structure as a function of prothrombinase activity, as well as intra-clot
differences in structure as a function of spatial location within the clot.
As anticipated from the polymerization data, clots formed during high thrombin generation
rates had ~15% thinner fibers and a 14% denser fibrin network than clots formed during low
thrombin generation rates (compare Figures 1a, 1d with 1b, 1e, respectively, Table II).
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Remarkably, however, the network density was ~25% higher in regions proximal (0 – 10 μm)
versus distal to (40 – 50 μm) the cell surface regardless of the thrombin generation rate
(compare Figures 1a, 1b with 1d, 1e, respectively, Table II). In contrast, fiber thickness did not
change as a function of distance from the cell surface (Table II). Of note, however, fiber
diameter (200–400 nm) is near the lower resolution limit for LSCM (~200 nm)5, 18, such that
subtle changes may not be apparent. Nonetheless, the spatial-dependence of fibrin density in
clots formed during in situ thrombin generation on the cell surface suggested that cells modulate
the three-dimensional structure of the clot.
In situ thrombin generation on fibroblasts modulates fibrin structural characteristics
independently of RGD-binding integrins
The structural heterogeneity of clots formed over fibroblasts suggested that localization of
thrombin generation on the cell surface and/or cellular interactions with the fibrin network
influenced the clot’s structure. We therefore examined the influence of cellular receptors on
fibrin structure in these clots. Previous studies have shown that cellular integrins bind fibrin
(ogen)19–21, and that the αvβ3 andαIIbβ3 integrins can directly modulate fibrin structure on
human umbilical vein endothelial cells (HUVEC) and platelets, respectively.22–24 Since the
fibroblasts used in our study expressed both αv and β3 subunits (data not shown)19–21, 25, we
examined the influence of αvβ3 and other RGD-binding integrins on fibrin architecture by
comparing clots formed in the presence and absence of the integrin-blocking peptide, RGDS
(500 μM, final). This concentration of RGDS peptide inhibited platelet aggregation but did not
alter the rates of thrombin generation or fibrin polymerization (data not shown). As seen in the
absence of RGDS, the mean network density was ~25% higher in regions proximal (0 – 10
μm) versus distal (40 – 50 μm) to the cell surface (Table II). The mean network density was
identical with and without RGDS (compare Figures 1d and 1e with 1g and 1h, respectively,
Table II), suggesting that neither αvβ3, αIIbβ3, nor other RGD-binding integrins caused the
spatially-dependent morphology seen in clots formed during in situ thrombin generation.
To further confirm that RGD-binding integrins did not influence fibrin structure in clots formed
on fibroblasts, we triggered clot formation with the addition of a single, monodispersed
thrombin concentration to a fibrinogen/calcium solution. These reactions bypass in situ
thrombin generation, so that fibrin structure arises from a uniform thrombin concentration
distributed throughout the reaction. Previous studies of clots formed over HUVEC23 and
platelets24 demonstrated that integrin-mediated influences on fibrin structure are detectable
following exogenous thrombin addition. Under these conditions, the mean network density in
regions proximal (0–10 μm) and distal (40–50 μm) to the cell surface were indistinguishable
(Figures 1c, 1f, Table II), and addition of RGDS peptide did not alter the fibrin appearance
(compare Figures 1f and 1i, Table II). These findings suggest that in situ thrombin generation
on the cell surface induces the formation of spatially-dependent fibrin morphology independent
of RGD-binding integrins.
In situ thrombin generation on fibroblasts modulates fibrin structure
To precisely determine the distance over which cells influence fibrin structure, we quantified
fiber diameter and network density in successive images recorded as the focal plane of the
LSCM progressed from 0 to 10 and 40 to 50 μm from the cell surface (Figure 2). As seen in
the 10-μm sections, fiber diameter measurements did not change as a function of distance from
the cell surface in any clots examined (Figure S2), possibly reflecting LSCM resolution limits.
Conversely, clots formed during in situ thrombin generation, exhibited a significant decrease
in network density (48% ± 10.7% and 51% ± 2.9% for 0.014 μM and 1.4 μM prothrombin,
respectively) between 0 and 10 μm from the cell surface, and a minor further decrease in
network density between 40 and 50 μm from the cell surface (Figure 2). The morphology was
seen in both the presence and absence of RGDS peptide. Surprisingly, although the global
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network was similar proximal and distal to the cell surface in clots formed by exogenous
thrombin addition (Figure 1, Table II), we did find a local decrease in network density (~11%)
between 0 and ~4 μm in these clots (Figure 2), in both the presence and absence of RGDS
peptide (Figure S3). To confirm that the decrease was not due to non-specific chamber surface
effects on the fibrin network, we formed clots in the absence of cells via exogenous thrombin
addition to a fibrinogen/calcium solution. Under these conditions, clots showed no change in
network density from 0–50 μm from the surface (Figure 2). Together, these findings suggest
that fibroblasts modulate fibrin structure over a short distance (< 4 μm) via a non-RGD-
dependent receptor, however, thrombin generation is the predominant determinant of fibrin
structure in these clots.
In situ thrombin generation on a cell surface modulates the rates of fibrin formation and lysis
as a function of distance from the cell surface
Since the thrombin concentration modulates the fibrin formation rate and resistance to
fibrinolysis5–11, we explicitly determined how in situ thrombin generation on the cell surface
affected the spatial and temporal aspects of fibrin formation and lysis. We incubated fibroblasts
with purified prothrombinase and included plasmin at the reaction start to uniformly disperse
plasmin throughout the clotting milieu. In this assay, fibrin formation competes with lysis, and
fibrin formation and lysis occur as a function of the thrombin generation rate and network
quality.8, 15, 26
During low thrombin generation rates (0.014 μM prothrombin), fibrin formed proximal, but
not distal to the cell surface within 50 seconds (Figure 3, Movies S4A, S4B). After two minutes,
fibrin was present proximal and distal to the cell surface. Fibrin distal to (50 μm above) the
cell surface lysed 328 ± 82 seconds prior to lysis at the cell surface. During high thrombin
generation rates (1.4 μM prothrombin), we observed immediate fibrin formation near the cell
surface < 15 seconds after clotting was initiated (Figure 3, Movies S4C, S4D). As in reactions
with low thrombin generation, fibrin appearance proximal to the surface preceded that distal
to (50 μm above) the cell surface, and fibrin lysed above the cell surface 449 ± 47 seconds
prior to lysis near the cell surface. Interestingly, the lysis rate (decrease in fiber number/μm2
versus time) was higher near versus distal to the cell surface, consistent with prior observations
that fibers in clots with a tight network lyse more slowly than those in a loose network.9
In contrast, clots produced by exogenous thrombin addition demonstrated essentially
simultaneous fibrin formation through the chamber at ~50 seconds (Figure 3). The large
variability in clots formed by exogenous thrombin addition likely results from the technical
challenge of initiating clot formation by thrombin addition; fibrin formation begins as the
solution is being transferred, causing variability in clot structure. Regardless, this control
experiment shows that differences in the rates of fibrin formation and lysis proximal versus
distal to the cell surface were not simply due to differences in the plasmin distribution or release
of plasmin inhibitors from the cell. Together these findings demonstrate that thrombin
generation on a cell surface increases fibrin formation and resistance to lysis near the cell
surface versus distal regions within the clot.
Cells modulate the network density of plasma clots
Finally, we examined whether in situ thrombin generation on fibroblasts modulated the three-
dimensional structure of plasma clots. Clots were formed as described in Methods, and fibrin
density was examined using LSCM and TEM. As depicted in Figure 4, plasma clots exhibited
denser fibrin network near the fibroblast surface versus 50 μm above the cell surface. The
denser network was not abolished by addition of RGDS peptide, suggesting RGDS-binding
integrins did not mediate this interaction. TEM confirmed these findings, demonstrating 4-fold
more fibers proximal (~1 μm) versus distal to (~5 μm away) the cell surface (Figure 4c–4d).
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In contrast, clots formed in the absence of cells (via slow contact initiation) demonstrated a
uniform distribution of thicker fibers. These findings support our LSCM observations and
demonstrate that in situ thrombin generation on a cell surface modulates plasma clot structure.
DISCUSSION
Previous studies have made three basic observations with regard to fibrin clot formation and
stability. First, blood coagulation is spatially non-uniform, with extrinsic and intrinsic activities
differentially modulating the initiation and propagation of fibrin formation in space.12 Second,
the concentration of thrombin present during fibrin gelation dictates the architecture of the
fibrin clot.5–9 Third, the fibrin clot quality influences its susceptibility to fibrinolysis.8–11
Together these observations suggest that when thrombin generation is localized to a cell
surface, the structure and stability of the resulting clot depends on cellular procoagulant activity
and the location within the clot with respect to the cell surface. In the current study, we
examined the influence of in situ thrombin generation on a cell surface on the spatial dynamics
of fibrin clot formation, structure, and lysis. Our findings demonstrate that in situ thrombin
generation on a cell surface causes the formation of a structurally heterogeneous clot, with a
denser fibrin network that is resistant to fibrinolysis proximal to the cell surface compared to
distal regions of the clot. These novel findings demonstrate the importance of the cell as a site
of localized procoagulant activity in determining clot structure and stability.
The predominant mechanism causing the spatially-heterogenous morphology is likely due to
differential rates of thrombin generation at and above the cell surface. Thrombin generation at
the cell surface is accelerated by lipid, which offers a ~6-fold increase in the Vmax relative to
the absence of lipid (at sites distal to the surface)27 Additionally, both mathematical simulations
and in vitro studies predict that the diffusional limit of procoagulant enzymes through the fibrin/
platelet layer limits thrombus height.28, 29 Our experiments were performed under static
conditions (lack of flow), however, this morphology may be enhanced by the removal of
thrombin distal to the cells by flowing blood.29 The movement of thrombin away from the cell
surface is likely limited directly by the diffusion rate and indirectly by thrombin binding sites
on fibrin, further impeding its progress through the gel matrix. Thus, the influence of the fibrin
network quality on thrombus growth is likely to be complex. Although the fibroblasts used in
our study express fibrinogen-binding integrin subunits (αv and β3), we did not see an effect of
these subunits on fibrin structure. This lack of integrin effect contrasts that previously seen on
platelets and HUVEC22–24, but may reflect decreased relative density of integrins on the
surface of fibroblasts versus other cells. We observed a minor effect of the cells on fibrin
structure in clots formed by exogenous thrombin addition that was not blocked by RGD-
containing peptides. Besides integrins, vascular endothelial-cadherin30 and intercellular
adhesion molecule-1 (ICAM-1)21, 31 also bind fibrin(ogen). Preliminary experiments
demonstrate that ICAM-1-blocking antibodies do not alter fibrin structure, suggesting that
ICAM-1 does not influence fibrin structure on these cells. Further studies are ongoing to
identify the nature of these interactions.
Cellular procoagulant activity is determined by expression of pro- and anti-coagulant
molecules. For example, cells expressing high levels of tissue factor and phosphatidylserine
support higher rates of thrombin generation.12 Conversely, expression of tissue factor pathway
inhibitor and thrombomodulin down-regulate thrombin generation.32, 33 Cells also up- and
down-regulate fibrinolysis via release of tPA and PAI-1, respectively 34, which may be
expected to modulate lysis of fibrin proximal to the cell, prior to affecting fibrin distal to the
cell. As with pro- and anti-coagulant activities, expression of these pro- and anti-fibrinolytic
activities are unique to different cells and vascular beds.35 Moreover, pathologic triggers
(e.g., infection, inflammation, stasis) differently modulate the expression of these activities on
different cell types.35 Given our findings, it is likely that different cell types in different vascular
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beds would uniquely and specifically regulate procoagulant and fibrinolytic activities
following vascular injury or pathologic insult, and therefore, the formation, structure and
stability of fibrin. The net influence of these cellular differences on fibrin quality may account,
at least in part, for vascular bed-specific fibrin deposition observed in various studies.36–38
A growing number of studies suggest that abnormal fibrin structure contributes to an
individual’s risk of arterial thrombosis.1–3 We have previously shown that elevated
prothrombin levels produce clots composed of an abnormally dense network composed of thin
fibrin fibers14, suggesting that abnormal fibrin structure contributes to the increased risk of
venous thromboembolism in patients with the G20210A mutation.39 It has also been
hypothesized that abnormal clot quality contributes to the risk of pulmonary embolism
following deep vein thrombosis.4 Our study demonstrated fibrinolysis distal to the cell surface
prior to proximal to the surface, consistent with processes thought to occur under normal
conditions in vivo. However, structurally inadequate regions within a clot, poor-anchoring of
intravascular clots to the vessel wall, or increased cell-derived fibrinolytic activity that triggers
premature lysis of fibrin proximal to the cell surface may promote embolization in vivo. Further
studies are warranted to understand the relationship between fibrin structure, stability, and
embolization.
In summary, our findings demonstrate for the first time that cellular procoagulant activity
dictates clot structure and stability as functions of not only the rate of thrombin generation, but
also the three-dimensional location of fibrin within the clot. Specifically, during in situ
thrombin generation, fibrin forms more quickly, assumes a denser network, and is relatively
resistant to lysis proximal to the procoagulant cell surface versus distal. This morphology can
arise independently of direct interactions between cellular receptors and the fibrin network,
but may be further modulated by cellular receptors on certain cells. This study is a first step in
understanding how cells contribute to fibrin formation. Identifying specific cellular influences
on fibrin structure is essential for determining antithrombotic targets for preventing thrombus
formation or stabilizing fibrin clots to prevent embolism.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
a) Sources of Funding - This study was supported by NIH grants K01 AR051021 (ASW) and T32 ES007017 (RAC),
and the Gustavus and Louise Pfeiffer Research Foundation (ASW).
b) The authors thank Drs. Susan Lord and Oleg Gorkun for their thoughtful contributions and Ms. Victoria Madden,
Ms. Laura Gray, and Ms. Brittany Larson for their excellent technical assistance.
c) Disclosure - One author (ASW) has received research funding from Novo Nordisk, Inc. within the last two years.
References
1. Collet JP, Allali Y, Lesty C, Tanguy ML, Silvain J, Ankri A, Blanchet B, Dumaine R, Gianetti J, Payot
L, Weisel JW, Montalescot G. Altered fibrin architecture is associated with hypofibrinolysis and
premature coronary atherothrombosis. Arterioscler Thromb Vasc Biol 2006;26:2567–2573. [PubMed:
16917107]
2. Fatah K, Hamsten A, Blomback B, Blomback M. Fibrin gel network characteristics and coronary heart
disease: relations to plasma fibrinogen concentration, acute phase protein, serum lipoproteins and
coronary atherosclerosis. Thromb Haemost 1992;68:130–135. [PubMed: 1384157]
Campbell et al. Page 7













3. Fatah K, Silveira A, Tornvall P, Karpe F, Blomback M, Hamsten A. Proneness to formation of tight
and rigid fibrin gel structures in men with myocardial infarction at a young age. Thromb Haemost
1996;76:535–540. [PubMed: 8902992]
4. Bounameaux H. Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary
embolism. Lancet 2000;356:182–183. [PubMed: 10963193]
5. Blomback B, Carlsson K, Hessel B, Liljeborg A, Procyk R, Aslund N. Native fibrin gel networks
observed by 3D microscopy, permeation and turbidity. Biochim Biophys Acta 1989;997:96–110.
[PubMed: 2752057]
6. Blomback B, Carlsson K, Fatah K, Hessel B, Procyk R. Fibrin in human plasma: gel architectures
governed by rate and nature of fibrinogen activation. Thromb Res 1994;75:521–538. [PubMed:
7992253]
7. Carr ME Jr, Hermans J. Size and density of fibrin fibers from turbidity. Macromolecules 1978;11:46–
50. [PubMed: 621951]
8. Wolberg AS, Allen GA, Monroe DM, Hedner U, Roberts HR, Hoffman M. High dose factor VIIa
improves clot structure and stability in a model of haemophilia B. Br J Haematol 2005;131:645–655.
[PubMed: 16351642]
9. Collet JP, Park D, Lesty C, Soria J, Soria C, Montalescot G, Weisel JW. Influence of fibrin network
conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by
confocal microscopy. Arterioscler Thromb Vasc Biol 2000;20:1354–1361. [PubMed: 10807754]
10. Carr ME Jr, Alving BM. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.
Blood Coagul Fibrinolysis 1995;6:567–573. [PubMed: 7578900]
11. Collet JP, Lesty C, Montalescot G, Weisel JW. Dynamic changes of fibrin architecture during fibrin
formation and intrinsic fibrinolysis of fibrin-rich clots. J Biol Chem 2003;278:21331–21335.
[PubMed: 12642590]
12. Ovanesov MV, Ananyeva NM, Panteleev MA, Ataullakhanov FI, Saenko EL. Initiation and
propagation of coagulation from tissue factor-bearing cell monolayers to plasma: initiator cells do
not regulate spatial growth rate. J Thromb Haemost 2005;3:321–331. [PubMed: 15670039]
13. Campbell RA, Fischer TH, Wolberg AS. A novel approach to improving recombinant factor VIIa
activity with a preserved platelet preparation. Br J Haematol 2007;138:82–93. [PubMed: 17555451]
14. Wolberg AS, Monroe DM, Roberts HR, Hoffman M. Elevated prothrombin results in clots with an
altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood 2003;101:3008–
3013. [PubMed: 12506014]
15. Allen GA, Persson E, Campbell RA, Ezban M, Hedner U, Wolberg AS. A variant of recombinant
factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of
hemophilia. Arterioscler Thromb Vasc Biol 2007;27:683–689. [PubMed: 17204663]
16. Chernysh IN, Weisel JW. Dynamic imaging of fibrin network formation correlated with other
measures of polymerization. Blood 2008;111:4854–4861. [PubMed: 18272815]
17. Weisel JW, Nagaswami C. Computer modeling of fibrin polymerization kinetics correlated with
electron microscope and turbidity observations: clot structure and assembly are kinetically controlled.
Biophys J 1992;63:111–128. [PubMed: 1420861]
18. Collet JP, Moen JL, Veklich YI, Gorkun OV, Lord ST, Montalescot G, Weisel JW. The alphaC
domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its
susceptibility to fibrinolysis. Blood 2005;106:3824–3830. [PubMed: 16091450]
19. Plow EF, Pierschbacher MD, Ruoslahti E, Marguerie GA, Ginsberg MH. The effect of Arg-Gly-Asp-
containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci
U S A 1985;82:8057–8061. [PubMed: 3877935]
20. Gailit J, Clarke C, Newman D, Tonnesen MG, Mosesson MW, Clark RA. Human fibroblasts bind
directly to fibrinogen at RGD sites through integrin alpha(v)beta3. Exp Cell Res 1997;232:118–126.
[PubMed: 9141628]
21. Farrell DH, al-Mondhiry HA. Human fibroblast adhesion to fibrinogen. Biochemistry 1997;36:1123–
1128. [PubMed: 9033403]
22. Collet JP, Montalescot G, Lesty C, Soria J, Mishal Z, Thomas D, Soria C. Disaggregation of in vitro
preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis.
Arterioscler Thromb Vasc Biol 2001;21:142–148. [PubMed: 11145946]
Campbell et al. Page 8













23. Jerome WG, Handt S, Hantgan RR. Endothelial cells organize fibrin clots into structures that are
more resistant to lysis. Microsc Microanal 2005;11:268–277. [PubMed: 16060980]
24. Collet JP, Montalescot G, Lesty C, Weisel JW. A structural and dynamic investigation of the
facilitating effect of glycoprotein IIb/IIIa inhibitors in dissolving platelet-rich clots. Circ Res
2002;90:428–434. [PubMed: 11884372]
25. Podolnikova NP, Yakubenko VP, Volkov GL, Plow EF, Ugarova TP. Identification of a novel binding
site for platelet integrins alpha IIb beta 3 (GPIIbIIIa) and alpha 5 beta 1 in the gamma C-domain of
fibrinogen. J Biol Chem 2003;278:32251–32258. [PubMed: 12799374]
26. Wolberg AS, Gabriel DA, Hoffman M. Analyzing fibrin clot structure using a microplate reader.
Blood Coagul Fibrinolysis 2002;13:533–539. [PubMed: 12192305]
27. Rosing J, Tans G, Govers-Riemslag JW, Zwaal RF, Hemker HC. The role of phospholipids and factor
Va in the prothrombinase complex. J Biol Chem 1980;255:274–283. [PubMed: 7350159]
28. Hathcock JJ, Nemerson Y. Platelet deposition inhibits tissue factor activity: in vitro clots are
impermeable to factor Xa. Blood 2004;104:123–127. [PubMed: 15016647]
29. Guy RD, Fogelson AL, Keener JP. Fibrin gel formation in a shear flow. Math Med Biol 2007;24:111–
130. [PubMed: 17018571]
30. Bach TL, Barsigian C, Yaen CH, Martinez J. Endothelial cell VE-cadherin functions as a receptor
for the beta15–42 sequence of fibrin. J Biol Chem 1998;273:30719–30728. [PubMed: 9804847]
31. Languino LR, Plescia J, Duperray A, Brian AA, Plow EF, Geltosky JE, Altieri DC. Fibrinogen
mediates leukocyte adhesion to vascular endothelium through an ICAM-1-dependent pathway. Cell
1993;73:1423–1434. [PubMed: 8100742]
32. Broze GJ Jr, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated
coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight
into its possible mechanism of action. Blood 1988;71:335–343. [PubMed: 3422166]
33. Esmon CT. Molecular events that control the protein C anticoagulant pathway. Thromb Haemost
1993;70:29–35. [PubMed: 8236111]
34. Shats EA, Nair CH, Dhall DP. Interaction of endothelial cells and fibroblasts with modified fibrin
networks: role in atherosclerosis. Atherosclerosis 1997;129:9–15. [PubMed: 9069511]
35. Aird WC. Vascular bed-specific thrombosis. J Thromb Haemost 2007;5 (Suppl 1):283–291.
[PubMed: 17635738]
36. Weiler-Guettler H, Christie PD, Beeler DL, Healy AM, Hancock WW, Rayburn H, Edelberg JM,
Rosenberg RD. A targeted point mutation in thrombomodulin generates viable mice with a
prethrombotic state. J Clin Invest 1998;101:1983–1991. [PubMed: 9576763]
37. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ,
Collen D, Mulligan RC. Physiological consequences of loss of plasminogen activator gene function
in mice. Nature 1994;368:419–424. [PubMed: 8133887]
38. Maroney SA, Cooley BC, Sood R, Weiler H, Mast AE. Combined tissue factor pathway inhibitor and
thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin
deposition. J Thromb Haemost 2008;6:111–117. [PubMed: 17973652]
39. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated
region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase
in venous thrombosis. Blood 1996;88:3698–3703. [PubMed: 8916933]
Campbell et al. Page 9













Figure 1. In situ thrombin generation on the cell surface modulates clot structure in three
dimensions
Clots were formed as described in the Methods in the absence (a–f) or presence (g–i) of RGDS
peptide. Three-dimensional projections show clot architecture in 10-μm sections at (0–10 μm)
and above (40–50 μm) the cell surface. Each image is from one experiment, representative of
3–6 independent experiments. Darker areas show increased fibrin density. Bar = 10 μm.
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Figure 2. Fibrin structure is determined by the distance from the cell surface
A) Images from one experiment in which clots were formed by combining factors Xa, Va, II,
fibrinogen, and CaCl2 (1 nM, 5 nM, 1.4 μM, 2 mg/mL, and 5 mM, respectively) as described
in the Methods. a) Differential interference contrast image. b – k) Individuals slices every 1.08
μm in the z-plane: b) 0, c) 1.08, d) 2.16, e) 3.24, f) 4.32, g) 5.4, h) 6.48, i) 7.56, j) 8.64, and k)
9.72 μm from the cell surface. Darker areas show increased fibrin density. Bar = 10 μm. B)
Fibrin network density (± standard error) was determined as described in Methods in the
presence of cells with 0.014 μM prothrombin (circles), 1.4 μM prothrombin (squares), 2 nM
thrombin (diamonds), or in the absence of cells with 2 nM thrombin (triangles).
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Figure 3. Clot formation and lysis are determined by the distance from the cell surface
Factors Xa, Va, prothrombin, fibrinogen, and CaCl2 were combined in the presence of plasmin,
as described in Methods. A) Images are from one experiment, representative of four
independent experiments. Images are the same size as in figure 1. The circular lysis pattern
reflects the distribution of light power across the lens (30% greater in the center than at the
periphery at 63× oil objective). B) Change in the fiber number over time (± standard error, n
= 4 – 6) in clots formed over cells with 0.014 μM prothrombin (circles), 1.4 μM prothrombin
(squares), or 2 nM thrombin (diamonds), at (open symbols) and above (closed symbols) the
cell surface. C) Fiber formation was defined as the first appearance of fibers in the field of
view. D) Fiber lysis was defined as the disappearance of all fibers in the field of view.
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Figure 4. Cells modulate the network density of plasma clots
Re-calcified PFP was incubated with or without fibroblasts, as described in the Methods. A)
Three-dimensional projections show clot architecture in 10 μm sections at (0–10 μm) and above
(40–50 μm) the cell surface. Each image is from one experiment, representative of 2
independent experiments. Bar = 10 μm. B) Fibrin network density (± standard deviation) in
the absence and presence (open and closed symbols, respectively) of 500 μM RGDS. C) TEMs
of fibrin fibers (black dots) in clots formed in the presence or absence of fibroblasts. In both
images, the bottom of the reaction chamber is oriented at the bottom of the image. Bar = 1
μm. D) Fibrin fibers were counted on micrographs recorded at 6300X by placing a 1-μm thick
box parallel to the cell surface 0.25 μm and 5 μm from the cell surface and counting fibers
inside the box.
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TABLE I
Properties of Clots Formed by in situ Thrombin Generation
Thrombin Generation Rate (nM/min) Clotting Onset (seconds) Fibrin Polymerization Rate (mOD/min) Final Turbidity at 405 nm
0.014 μM 0.402 ± 0.11 77 ± 5.0 77 ± 7.2 0.589 ± 0.12
1.4 μM 16.3 ± 5.44 33 ± 14.6 168 ± 20.3 0.536 ± 0.11
P <0.007 < 0.008 < 0.002 NS
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